Tengshengbo Pharmaceutical-B (02137) announced that Mr. Robert Taylor Nelsen... has been appointed as a non-executive director whose term will expire on July 12, 2024. Mr. Nelsen has confirmed that due to his increasing new business and responsibilities, he will not renew his contract after this term expires. Mr. Nelsen will also step down as a member of the board of directors' strategic committee. In recognition of his valuable contributions to the company during his term in office since 2018, the board of directors invited Mr. Nelsen to become a member of the company's scientific advisory committee, effective July 13, 2024, and provide consulting services on the company's research and development through high-level strategic guidance and advice.
According to the CHINA TOP NEWS app, Tengshengbo Pharmaceutical-B (02137) announced that Mr. Robert Taylor Nelsen's term as a non-executive director will expire on July 12, 2024. Mr. Nelsen has confirmed that due to his increasing new business and responsibilities, he will not renew his contract after this term expires. Mr. Nelsen will also step down as a member of the board of directors' strategic committee. In recognition of his valuable contributions to the company during his term in office since 2018, the board of directors invited Mr. Nelsen to become a member of the company's scientific advisory committee, effective July 13, 2024, and provide consulting services on the company's research and development through high-level strategic guidance and advice.